Preclinical Tomography System Sales

Preclinical Tomography System Sales Market Outlook

The global preclinical tomography system market is projected to reach approximately USD 2.8 billion by 2035, growing at a Compound Annual Growth Rate (CAGR) of around 8.5% from 2025 to 2035. This growth can be attributed to several key factors including the increasing prevalence of chronic diseases, the rise in research activities in drug development, and advancements in imaging technologies. Moreover, growing investments in preclinical research by pharmaceutical and biotechnology companies also contribute significantly to the expansion of this market. The trend towards personalized medicine and the need for more accurate diagnostic tools in laboratory settings are expected to further drive market growth, as researchers seek advanced imaging technologies to facilitate their studies. Additionally, the integration of artificial intelligence in imaging systems for enhanced diagnostics and therapeutic monitoring is anticipated to revolutionize the marketplace.

Growth Factor of the Market

The preclinical tomography system sales market is experiencing significant growth due to various factors. Firstly, the heightened focus on precision medicine and the need for accurate preclinical testing are propelling demand for advanced imaging systems. Secondly, the rise in funding for research activities in both public and private sectors has led to a surge in the procurement of preclinical imaging equipment. Furthermore, the increasing number of collaborations between academia and industry to advance drug discovery is triggering a greater need for effective imaging solutions. Rapid technological advancements, such as the development of hybrid imaging systems that combine multiple modalities, are also playing a vital role in market expansion. Lastly, the growing prevalence of chronic diseases necessitates more efficient research and analysis, thereby boosting the market for preclinical tomography systems.

Key Highlights of the Market

• Projected growth to USD 2.8 billion by 2035, with a CAGR of 8.5% from 2025 to 2035.
• Increased investments in R&D activities by pharmaceutical and biotechnology companies.
• Adoption of advanced imaging technologies to enhance diagnostic accuracy.
• Collaboration between academic and industrial sectors to foster innovative drug testing.
• Integration of AI technologies to improve efficiency in imaging processes.

By Product Type

CT Scanners:

CT scanners hold a substantial share in the preclinical tomography system market. These systems are favored for their ability to provide detailed cross-sectional images of the body, enabling researchers to visualize intricate anatomical structures. The advancements in computed tomography technology, such as the introduction of high-resolution detectors and improved image reconstruction algorithms, have significantly enhanced the capabilities of CT scanners. As a result, they are increasingly used in preclinical research for applications such as oncology and cardiology, where detailed imaging is crucial for accurate disease characterization and treatment planning. The demand for CT scanners is projected to grow as the need for rapid and reliable diagnostic tools increases in preclinical studies.

MRI Systems:

MRI systems are another critical segment of the preclinical tomography system market. They provide high-resolution images without the risks associated with ionizing radiation, making them ideal for longitudinal studies in research settings. The technological innovations in MRI, including the development of ultra-high-field MRI systems, have expanded the scope of preclinical research applications, particularly in neurology and oncology. These advanced systems facilitate the visualization of subtle changes in tissue composition and structure, providing invaluable data for researchers. As the field of neuroscience continues to grow, the demand for MRI systems in preclinical research is expected to rise, driving market growth in this segment.

PET/SPECT Systems:

Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) systems are essential tools in preclinical studies, particularly for assessing metabolic activity and functional imaging of diseases. The integration of PET and SPECT with other imaging modalities, such as MRI, has led to the development of hybrid systems that provide both anatomical and functional information. This combination enhances the ability to track disease progression and treatment efficacy in animal models. As the trend towards personalized medicine continues to grow, the reliance on PET/SPECT systems for preclinical applications is anticipated to increase, further propelling the market forward.

Optical Imaging Systems:

Optical imaging systems are gaining traction in the preclinical tomography system market due to their non-invasive nature and capability to provide real-time imaging. Techniques such as fluorescence imaging and bioluminescence imaging allow researchers to study cellular and molecular processes in live subjects. These systems are particularly useful in oncology and immunology applications, allowing for the visualization of tumor growth and immune response in preclinical models. The increasing demand for fast and sensitive imaging techniques is expected to drive the growth of optical imaging systems in preclinical research, making them a valuable asset in laboratories worldwide.

Ultrasound Systems:

Ultrasound systems are becoming an integral part of the preclinical imaging landscape, particularly due to their cost-effectiveness and real-time imaging capabilities. They are frequently used to evaluate physiological and hemodynamic parameters in animal models, providing significant insights during preclinical trials. The advancement of high-frequency ultrasound technology has further expanded its application in detailed imaging, making it suitable for small animal studies in various fields, including cardiology and orthopedics. The growing recognition of the benefits of ultrasound systems in preclinical research is likely to contribute to their increasing adoption, enhancing their market presence.

By Application

Oncology:

Oncology is one of the leading applications for preclinical tomography systems. The rising incidence of cancer and the extensive need for research into novel therapeutic agents drive the demand for advanced imaging technologies for tumor detection and monitoring. Preclinical imaging systems, such as MRI, PET, and CT scanners, enable researchers to visualize tumor progression and response to therapies in animal models. This visualization provides critical insights that inform clinical trial designs and therapeutic strategies. As cancer research continues to evolve, the need for sophisticated imaging solutions in preclinical oncology studies is expected to grow significantly.

Neurology:

Neurology is another key application area where preclinical tomography systems play a crucial role. Imaging modalities such as MRI and PET are extensively used to study neurological disorders, including Alzheimer’s disease and other neurodegenerative conditions. These systems facilitate the evaluation of brain structure and function, enabling researchers to monitor disease progression and assess the efficacy of potential treatments. The increasing focus on neurological disorders and the need for innovative therapies are likely to enhance the demand for advanced imaging technologies in preclinical neurology research.

Cardiology:

In the field of cardiology, preclinical tomography systems are vital for studying heart diseases and evaluating therapeutic interventions. Imaging techniques, including echocardiography and MRI, are used to assess cardiac structure and function in animal models. The ability to visualize the impact of different treatment modalities on cardiovascular health is essential for advancing research in this area. As cardiovascular diseases remain a leading cause of morbidity and mortality worldwide, the demand for reliable imaging systems for preclinical studies in cardiology is anticipated to rise significantly.

Immunology:

The immunology application segment is experiencing growth within the preclinical tomography system market, as researchers seek to understand the immune system's response to various therapies and diseases. Optical imaging systems play a pivotal role in visualizing immune cell distribution and activity in live animal models, providing insights into the mechanisms of action of immunotherapeutic agents. The increased focus on immunotherapy and biologics in drug development is expected to drive demand for preclinical imaging systems in immunology, fostering advancements in treatment strategies.

Orthopedics:

Orthopedics represents a significant application area for preclinical tomography systems, particularly concerning bone health and musculoskeletal disorders. Techniques such as micro-CT and ultrasound are employed to study bone density, structure, and healing processes in animal models. The adoption of sophisticated imaging technologies allows researchers to better understand the effects of various treatment approaches on orthopedic conditions. As the prevalence of musculoskeletal disorders continues to rise, the demand for advanced imaging solutions in orthopedic research is expected to grow, thus enhancing the market for preclinical tomography systems.

By User

Hospitals & Clinics:

Hospitals and clinics represent a major end-user segment in the preclinical tomography system market. These facilities often engage in research alongside clinical practice, necessitating access to advanced imaging technologies for both diagnostic and research purposes. The increasing prevalence of chronic diseases and the need for precise diagnostic tools prompt hospitals and clinics to invest in preclinical imaging systems. Furthermore, collaborations between clinical and research departments enhance the utilization of these systems, driving market growth within this segment.

Research Institutes:

Research institutes play a crucial role as end-users of preclinical tomography systems, often engaged in extensive studies related to drug discovery and disease mechanisms. The need for high-quality imaging to support research activities leads to significant investments in advanced tomography systems. As the focus on translational research grows, research institutes are increasingly adopting novel imaging technologies to enhance their studies. The collaboration between research institutions and pharmaceutical companies further boosts the demand for preclinical imaging systems, thus impacting market growth positively.

Pharmaceutical & Biotechnology Companies:

Pharmaceutical and biotechnology companies are significant end-users of preclinical tomography systems, as these technologies are essential for drug development and evaluation processes. The ability to conduct comprehensive imaging studies in preclinical trials aids in understanding the pharmacokinetics and pharmacodynamics of new drug candidates. As the pharmaceutical industry increasingly recognizes the value of preclinical imaging in accelerating drug development timelines, the demand for advanced tomography systems within this segment is expected to rise sharply. The ongoing search for novel therapeutics, especially in oncology and immunology, will further spur market growth.

Contract Research Organizations:

Contract Research Organizations (CROs) are key stakeholders in the preclinical tomography system market, providing essential research services to pharmaceutical and biotechnology companies. These organizations often utilize advanced imaging technologies to support their clients' drug development efforts. The demand for preclinical imaging services provided by CROs is increasing due to the ongoing trend of outsourcing research activities by pharmaceutical companies. As CROs expand their capabilities and enhance their service offerings, the adoption of preclinical tomography systems is expected to continue growing, thereby contributing to market expansion.

Diagnostic Centers:

Diagnostic centers also represent a noteworthy end-user segment in the preclinical tomography system market. These facilities often employ advanced imaging technologies for diagnostic purposes and support research initiatives. The increasing demand for accurate and efficient diagnostic tools drives investments in preclinical imaging systems. Additionally, the role of diagnostic centers in early disease detection and monitoring boosts the need for advanced tomography solutions. As the healthcare landscape evolves, the involvement of diagnostic centers in preclinical research is anticipated to expand, thereby enhancing the market for tomography systems.

By Technology

Micro-CT:

Micro-CT technology is a vital component of the preclinical tomography system market, offering high-resolution imaging capabilities for small animal studies. This technology enables researchers to visualize fine anatomical structures and assess bone integrity, making it particularly relevant for applications in orthopedics and cancer research. The advancements in micro-CT systems, such as the development of novel imaging algorithms and enhanced detector sensitivity, have significantly improved imaging quality and speed. As researchers seek more precise imaging solutions for their studies, the demand for micro-CT technology in preclinical settings is expected to grow rapidly.

Micro-MRI:

Micro-MRI technology provides non-invasive imaging capabilities for studying soft tissues, making it essential for various preclinical research applications. This technology allows researchers to monitor disease progression and treatment efficacy in live animal models, particularly in neurology and oncology studies. The advancements in high-resolution MRI techniques have expanded the application scope for micro-MRI, enabling detailed visualization of smaller anatomical features. As the focus on understanding complex disease mechanisms intensifies, the demand for micro-MRI systems in preclinical research is anticipated to increase significantly.

Micro-PET:

Micro-PET technology is pivotal in preclinical tomography systems, providing insights into metabolic activity and functional imaging in small animal models. This imaging modality allows researchers to evaluate the efficacy of new therapeutic agents and monitor disease progression in real time. The integration of micro-PET with other imaging techniques, such as CT and MRI, enhances its capabilities by providing both anatomical and functional information. As the demand for personalized medicine grows, the reliance on micro-PET technology in preclinical research is expected to rise, propelling market growth in this sector.

Micro-SPECT:

Micro-SPECT technology complements preclinical imaging capabilities by providing valuable functional information through its ability to visualize biological processes in vivo. This technology is particularly advantageous for studying complex diseases, including cancer and cardiovascular disorders. The advancements in micro-SPECT systems, such as improved resolution and sensitivity, have made them indispensable in preclinical research. As researchers increasingly prioritize understanding the underlying mechanisms of diseases, the demand for micro-SPECT systems in preclinical settings is likely to continue growing.

Optical Imaging:

Optical imaging technology offers researchers the ability to visualize cellular and molecular processes in real time, making it a vital tool in preclinical studies. Techniques such as fluorescence and bioluminescence imaging enable the tracking of specific biological events and responses in live subjects. The non-invasive nature of optical imaging systems is appealing for longitudinal studies, allowing researchers to monitor changes over time without sacrificing the health of the model organism. As the focus on molecular imaging intensifies, the demand for optical imaging technologies in preclinical research is anticipated to rise, further enhancing their market presence.

By Region

The North America region is currently leading the preclinical tomography system market, accounting for approximately 45% of the overall market share. The region is characterized by a robust healthcare infrastructure, significant investments in research and development, and the presence of key players in the imaging technology sector. Furthermore, the increasing prevalence of chronic diseases and growing demand for advanced imaging solutions in both academic and commercial settings are driving market growth in North America. The CAGR for the North American market is expected to be around 8.2% from 2025 to 2035, reflecting sustained growth in this highly competitive landscape.

Europe holds the second-largest share in the preclinical tomography system market, representing approximately 30% of the total market. The region’s growth is propelled by increasing collaborations between research institutions and pharmaceutical companies, as well as rising investments in preclinical research. Countries such as Germany, France, and the United Kingdom are at the forefront of this growth, driven by advancements in imaging technologies and a strong focus on innovative drug development. The European market is projected to grow at a CAGR of 9% from 2025 to 2035, indicating a healthy expansion trajectory.

Opportunities

There are numerous opportunities within the preclinical tomography system market that stakeholders can leverage for growth and advancement. One of the primary opportunities lies in the increasing demand for personalized medicine, which requires precise imaging technologies to study individual responses to therapies. This trend is driving innovation in imaging modalities and encouraging the development of hybrid systems that integrate multiple imaging techniques for comprehensive analysis. Furthermore, the rise in drug development activities by biotechnology and pharmaceutical companies is leading to a higher demand for preclinical imaging systems. Companies that can provide cutting-edge imaging solutions tailored to the needs of researchers will find ample opportunities for growth in this evolving market.

Additionally, emerging markets in the Asia Pacific region present significant opportunities for preclinical tomography system manufacturers. As countries like China and India increase their focus on healthcare infrastructure and research capabilities, the demand for advanced imaging technologies is expected to rise. This presents a chance for companies to expand their footprint in these regions by establishing partnerships with local research institutions and healthcare providers. The increasing investments in biotechnology and pharmaceuticals in these markets will further drive the need for effective preclinical imaging solutions, creating a landscape rich with growth potential for industry players.

Threats

Despite the positive growth trajectory, there are several threats facing the preclinical tomography system market. One of the primary concerns is the rapid pace of technological advancements, which may render existing systems obsolete if manufacturers do not keep up with innovations. This threat necessitates ongoing investment in research and development to stay competitive. Additionally, the regulatory environment surrounding medical devices can pose challenges, as compliance with stringent regulations may require significant resources and time. The lengthy approval processes can delay the introduction of new imaging technologies to the market, potentially impacting sales and growth.

Another critical threat to the market is the increasing competition from alternative imaging modalities that may offer cost-effective solutions. For instance, advancements in ultrasound imaging could pose a challenge to traditional imaging techniques used in preclinical studies. As researchers seek budget-friendly options, there is a risk that conventional tomography systems may lose market share. Furthermore, the global economic uncertainties brought about by geopolitical tensions and market fluctuations can adversely affect funding for research activities, thereby impacting the overall demand for preclinical tomography systems. Businesses must remain vigilant and adaptable in navigating these shifting dynamics to mitigate potential threats.

Competitor Outlook

• Bruker Corporation
• Siemens Healthineers
• GE Healthcare
• Philips Healthcare
• PerkinElmer, Inc.
• Invicro LLC
• Mediso Medical Imaging Systems
• Miltenyi Biotec
• Aspect Imaging
• Rigaku Corporation
• Thermo Fisher Scientific
• Olympus Corporation
• Fujifilm Holdings Corporation
• Canon Medical Systems Corporation
• Hitachi Medical Corporation

The competitive landscape of the preclinical tomography system market is characterized by the presence of a diverse range of players, including established multinationals and emerging companies. Key manufacturers are actively involved in developing innovative imaging technologies that address the growing demands of preclinical research. Companies like Bruker Corporation and Siemens Healthineers lead the market with their comprehensive portfolios of advanced imaging systems. They invest significantly in research and development to enhance the performance and functionality of their products, ensuring they remain at the forefront of technological advancements.

GE Healthcare and Philips Healthcare are also major players in this market, offering a variety of preclinical imaging solutions tailored to meet the needs of research institutions and pharmaceutical companies. Their commitment to developing advanced imaging technologies and expanding their presence in emerging markets positions them strongly for future growth. Additionally, PerkinElmer and Invicro LLC are focusing on the integration of software solutions with imaging systems, facilitating enhanced data analysis and visualization capabilities that cater to the evolving requirements of researchers.

As the market continues to evolve, new entrants and niche players are emerging, offering specialized and innovative imaging solutions. Companies like Aspect Imaging and Mediso Medical Imaging Systems focus on providing unique imaging technologies that meet specific research needs. Their agility in addressing market demands allows them to carve out their niche in this competitive landscape. Overall, the preclinical tomography system market is poised for robust growth, driven by continuous innovation, strategic partnerships, and a commitment to meeting the diverse needs of the research community.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Invicro LLC
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 GE Healthcare
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Aspect Imaging
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Miltenyi Biotec
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 PerkinElmer, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Bruker Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Philips Healthcare
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Rigaku Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Olympus Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Siemens Healthineers
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Thermo Fisher Scientific
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Hitachi Medical Corporation
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Fujifilm Holdings Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Mediso Medical Imaging Systems
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Canon Medical Systems Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Preclinical Tomography System Sales Market, By User
    • 6.1.1 Hospitals & Clinics
    • 6.1.2 Research Institutes
    • 6.1.3 Pharmaceutical & Biotechnology Companies
    • 6.1.4 Contract Research Organizations
    • 6.1.5 Diagnostic Centers
  • 6.2 Preclinical Tomography System Sales Market, By Technology
    • 6.2.1 Micro-CT
    • 6.2.2 Micro-MRI
    • 6.2.3 Micro-PET
    • 6.2.4 Micro-SPECT
    • 6.2.5 Optical Imaging
  • 6.3 Preclinical Tomography System Sales Market, By Application
    • 6.3.1 Oncology
    • 6.3.2 Neurology
    • 6.3.3 Cardiology
    • 6.3.4 Immunology
    • 6.3.5 Orthopedics
  • 6.4 Preclinical Tomography System Sales Market, By Product Type
    • 6.4.1 CT Scanners
    • 6.4.2 MRI Systems
    • 6.4.3 PET/SPECT Systems
    • 6.4.4 Optical Imaging Systems
    • 6.4.5 Ultrasound Systems

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Preclinical Tomography System Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Preclinical Tomography System Sales market is categorized based on

By Product Type

• CT Scanners
• MRI Systems
• PET/SPECT Systems
• Optical Imaging Systems
• Ultrasound Systems

By Application

• Oncology
• Neurology
• Cardiology
• Immunology
• Orthopedics

By User

• Hospitals & Clinics
• Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Diagnostic Centers

By Technology

• Micro-CT
• Micro-MRI
• Micro-PET
• Micro-SPECT
• Optical Imaging

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Bruker Corporation
• Siemens Healthineers
• GE Healthcare
• Philips Healthcare
• PerkinElmer, Inc.
• Invicro LLC
• Mediso Medical Imaging Systems
• Miltenyi Biotec
• Aspect Imaging
• Rigaku Corporation
• Thermo Fisher Scientific
• Olympus Corporation
• Fujifilm Holdings Corporation
• Canon Medical Systems Corporation
• Hitachi Medical Corporation